Washington, DC (February 24, 2014)—A recent article in JAMA Otolaryngology reported a significant over-diagnosis of thyroid cancer. The study authors found that while incidence of thyroid cancer has nearly tripled since 1975, mortality rate from thyroid cancer between 1975 and 2009 remained stable. Endocrine Society member R. Michael Tuttle, MD, an expert on thyroid cancer, is prepared to offer comment on the many questions surrounding this issue, including:
The Endocrine Society and its members are concerned that patients legitimately diagnosed with thyroid cancer may second-guess their endocrinologists or may interrupt their treatment.
WHO:
R. Michael Tuttle, MD
Representative of the Endocrine Society
Endocrinologist, Memorial Sloan Kettering Cancer Center
Professor, Joan and Sanford I. Weill Medical College, Cornell University
WHAT:
Endocrine Society member R. Michael Tuttle, MD, is available to offer comment on the diagnosis and treatment of thyroid cancer.
CONTACT:
To schedule an interview, please contact Aaron Lohr at [email protected] or 202-971-3654.
About Endocrine Society
Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.
The Society has more than 18,000 members, including scientists, physicians, educators, nurses, and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on X (formerly Twitter) at @TheEndoSociety and @EndoMedia.
Colleen Williams Senior Communications Manager, Public Relations Phone: (202)-971-3611 [email protected]
Jenni Glenn Gingery Director, Communications and Media Relations Phone: (202)-971-3655 [email protected]